Showing results (41-50 of 285) with videos related to
Sort By:
Pageof 29
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 18, 2019
Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor TherapyMinjee Kim, Janice K Laramy, Gautham Gampa, et al.Neuro-Oncology|September 12, 2015
Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastomaRajneet K Oberoi, Karen E Parrish, Terence T Sio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2015
InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in GlioblastomaYufang Ma, Nan Tang, Reid C Thompson, et al.The Journal of Pharmacology and Experimental Therapeutics|September 22, 2022
Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain TumorsSurabhi Talele, Wenjuan Zhang, Jiajia Chen, et al.Frontiers in Neuroscience|July 3, 2015
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiformeAmanda Tivnan, Zaitun Zakaria, Caitrín O'Leary, et al.Oncogene|March 12, 2021
EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastomaAlan T Yeo, Hyun Jung Jun, Vicky A Appleman, et al.Molecular & Cellular Proteomics : MCP|September 12, 2012
Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenograftsHannah Johnson, Amanda M Del Rosario, Bryan D Bryson, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 2, 2019
Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient MiceMinjee Kim, Janice K Laramy, Afroz S Mohammad, et al.Neuro-Oncology|September 14, 2014
Critical functions of RhoB in support of glioblastoma tumorigenesisYufang Ma, Yuanying Gong, Zhixiang Cheng, et al.Journal of Neuro-Oncology|October 12, 2012
ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cellsAditi Nadkarni, Meena Shrivastav, Ann C Mladek, et al.Pageof 29